Search Results - "Chulanov, V"

Bulevirtide improves health-related quality of life measured by EQ-5D VAS in patients with chronic hepatitis delta: An exploratory analysis of a Phase 3 trial at 48 weeks by Buti, M., Wedemeyer, H., Aleman, S., Chulanov, V., Morozov, V., Sagalova, O., Stepanova, T., Gish, R. G, Lloyd, A., Kaushik, A. M, Suri, V., Manuilov, D., Osinusi, A. O, Flaherty, J., Pandey, S., Singh, B., Lampertico, P.

“…Chronic hepatitis delta (CHD) is the most severe form of viral hepatitis and is associated with rapid progression to cirrhosis, decompensation, hepatocellular…”
Get full text

Efficacy of bulevirtide as monotherapy for chronic hepatitis D (CHD): Week 48 results from an integrated analysis by Lampertico, P., Aleman, S., Blank, A., Bogomolov, P., Chulanov, V., Mamonova, N., Morozov, V., Sagalova, O., Stepanova, T., Suri, V., Manuilov, D., Ye, L., Flaherty, J.F., Osinusi, A., Cornberg, M., Brunetto, M., Wedemeyer, H.

“…Bulevirtide (BLV) is a novel first-in-class entry inhibitor for the treatment of chronic hepatitis delta virus (HDV) infection (CHD) that was conditionally…”
Get full text

Serological diagnosis and prevalence of HIV-1 infection in Russian metropolitan areas by Kireev, D E, Chulanov, V P, Shipulin, G A, Semenov, A V, Tivanova, E V, Kolyasnikova, N M, Zueva, E B, Pokrovskiy, V V, Galli, C

“…HIV infection is a major health problem in Russia. We aimed to assess HIV prevalence in different population groups and to compare the characteristics of 4th…”
Get full text

Antiviral Activity of CRISPR/Cas9 Ribonucleoprotein Complexes on a Hepatitis B Virus Model In Vivo by Kostyusheva, A. P., Brezgin, S. A., Ponomareva, N. I., Goptar, I. A., Nikiforova, A. V., Gegechkori, V. I., Poluektova, V. B., Turkadze, K. A., Sudina, A. E., Chulanov, V. P., Kostyushev, D. S.

“…Chronic hepatitis B (CHB) is caused by hepatitis B virus (HBV) infection. This disease is a key issue for global health. Modern methods of therapy do not…”
Get full text

Stochastic Packaging of Cas Proteins into Exosomes by Ponomareva, N I, Brezgin, S A, Kostyusheva, A P, Slatinskaya, O V, Bayurova, E O, Gordeychuk, I V, Maksimov, G V, Sokolova, D V, Babaeva, G, Khan, I I, Pokrovsky, V S, Lukashev, A S, Chulanov, V P, Kostyushev, D S

“…CRISPR/Cas systems are perspective molecular tools for targeted manipulation with genetic materials, such as gene editing, regulation of gene transcription,…”
Get more information

Stochastic Packaging of Cas Proteins into Exosomes by Ponomareva, N. I., Brezgin, S. A., Kostyusheva, A. P., Slatinskaya, O. V., Bayurova, E. O., Gordeychuk, I. V., Maksimov, G. V., Sokolova, D. V., Babaeva, G., Khan, I. I., Pokrovsky, V. S., Lukashev, A. S., Chulanov, V. P., Kostyushev, D. S.

“…—CRISPR/Cas systems are perspective molecular tools for targeted manipulation with genetic materials, such as gene editing, regulation of gene transcription,…”
Get full text

HBx Protein Potentiates Hepatitis B Virus Reactivation by Brezgin, S. A., Kostyusheva, A. P., Ponomareva, N. I., Gegechkori, V. I., Kirdyashkina, N. P., Ayvasyan, S. R., Dmitrieva, L. N., Kokoreva, L. N., Chulanov, V. P., Kostyushev, D. S.

“…Hepatitis B virus (HBV) can cause chronic hepatitis B, one of the most prevalent infectious diseases in the world. Global estimates suggest that over 2 billion…”
Get full text

Small Molecular Inhibitors of DNA Double Strand Break Repair Pathways Increase the ANTI-HBV Activity of CRISPR/Cas9 by Kostyusheva, A. P., Kostyushev, D. S., Brezgin, S. A., Zarifyan, D. N., Volchkova, E. V., Chulanov, V. P.

“…The CRISPR/Cas9 nuclease system can effectively suppress the replication of the hepatitis B virus (HBV), while covalently closed circular DNA (cccDNA), a…”
Get full text

Sofosbuvir/velpatasvir for the treatment of HCV: excellent results from a phase-3, open-label study in Russia and Sweden by Isakov, Vasily, Chulanov, Vladimir, Abdurakhmanov, Dzhamal, Burnevich, Eduard, Nurmukhametova, Elena, Kozhevnikova, Galina, Gankina, Natalya, Zhuravel, Sergey, Romanova, Svetlana, Hyland, Robert H., Lu, Sophia, Svarovskaia, Evguenia S., McNally, John, Brainard, Diana M., Ivashkin, Vladimir, Morozov, Vyacheslav, Bakulin, Igor, Lagging, Martin, Zhdanov, Konstantin, Weiland, Ola

“…Background: In both Russia and Sweden, the dominant hepatitis C virus (HCV) is genotype 1, but around one-third of patients have genotype 3 infection. For such…”
Get full text

P1285 : Forecasting the disease burden of chronic hepatitis C in Russia by Chulanov, V, Sagalova, O, Blokhina, N, Mamonova, N, Nurmukhametova, E, Pimenov, N, Rakhmanova, A, Razavi, H, Razavi-Shearer, K, Shevaldin, A, Chesnokov, E, Sokolov, S, Strebkova, E, Znoiko, O, Shestakova, I

Get full text

Efficacy and safety of narlaprevir/ritonavir and daclatasvir non interferon combination in population of Russian patients with chronic hepatitis C by Klimova, E A, Burnevich, E Z, Chulanov, V P, Gusev, D A, Znoyko, O O, Batskikh, S N, Kizlo, S N, Mamonova, N A, Tarkhova, E P, Krasavina, E N, Samsonov, M Yu, Yushchuk, N D

“…Aim. Evaluate efficacy and safety of a combination of direct - acting antivirals narlaprevir/ritonavir with daclatasvir in patients with viral hepatitis C…”
Get full text

Hepatitis C can be cured: will hepatitis B become next? by V P Chulanov, A P Zueva, D S Kostyushev, S A Brezgin, E V Volchkova, V V Maleyev

“…Chronic hepatitis B (CHB) and C (CHC) are one of the leading causes of cirrhosis and liver cancer with over a million of people dying annually from their…”
Get full text

INCREASED FORMATION OF PHOSPHORYLATED H2AX FOCI IN NUCLEI OF CELLS INFECTED BY HEPATITIS B AND B+D VIRUSES by Kostyushev, D. S., Brezgin, S. A., Kostyusheva, A. P., Lipatnikov, A. D., Simirskii, V. N., Mamonova, N. A., Volchkova, E. V., Maleyev, V. V., Chulanov, V. P.

“…Liver cirrhosis and hepatocellular carcinoma are the most common outcomes of chronic hepatitis B. Hepatitis B virus (HBV) induces transformation and cell death…”
Get full text

Pharmacoeconomic analysis of tixagevimab and cilgavimab combination for COVID-19 therapy by Zhuravleva, M. V., Chulanov, V. P., Gagarina, Yu. V., Shabalina, E. A.

“…Objective : to evaluate the pharmacoeconomic feasibility of using monoclonal antibodies or their combinations vs standard therapy in patients with mild and…”
Get full text

Overexpression of DNA-methyltransferases in persistency of cccDNA pool in chronic hepatitis B by D S Kostyushev, A P Zueva, S A Brezgin, A D Lipatnikov, V N Simirskii, D Glebe, E V Volchkova, G A Shipulin, V P Chulanov

“…Aim. To define the role of DNA-methyltransferases of type 1 and type 3A in hepatitis B viral cycle. Materials and methods. Human hepatoma cells HepG2 with…”
Get full text

P1299 PEARL-III: 12 WEEKS OF ABT-450/R/267 + ABT-333 ACHIEVED SVR IN >99% OF 419 TREATMENT-NAIVE HCV GENOTYPE 1B-INFECTED ADULTS WITH OR WITHOUT RIBAVIRIN by Ferenci, P, Nyberg, A, Enayati, P, Bernstein, D, Baruch, Y, Caruntu, F.A, Chulanov, V, Janczewska, E, Younes, Z, Marinho, R.T, Rizzardini, G, Gervain, J, Planas, R, Moreno, C, Xie, W, Cohen, D, King, M, Podsadecki, T, Reddy, K.R

Get full text

Resistance to protease inhibitors and efficiency of antiviral therapy in patients with chronic hepatitis C by Batskikh, S N, Karandashova, I V, Neverov, A D, Chulanov, V P

“…To clarify the role of virus resistance in the efficiency of antiviral therapy with protease inhibitors (PIs) chronic hepatitis C (CHC) patients, with moderate…”
Get full text

Epidemiological Features of the COVID-19 and Characteristics of Patients during the Spread of the Omicron SARS-COV-2 in Russia by Fomicheva, A. A., Pimenov, N. N., Komarova, S. V., Urtikov, A. V., Tsapkova, N. N., Sakhautdinov, A. R., Strelkova, D. A., Nekludova, G. V., Rachina, S. A., Avdeev, S. N., Chulanov, V. P.

“…Aim. To analyze dynamic of incidence and mortality of COVID-19 and clinical and epidemiological characteristics of adult patients with a new coronavirus…”
Get full text

Features of the covid-19 epidemic and characteristics of patients during the spread of the delta SARS-COV-2 in Russia by Fomicheva, A. A., Pimenov, N. N., Komarova, S. V., Urtikov, A. V., Tsapkova, N. N., Proshkina, A. A., De Silva, S. H.R., Vlasenko, A. E., Strelkova, D. A., Nekludova, G. V., Rachina, S. A., Avdeev, S. N., Chulanov, V. P.

“…Aim: To study the manifestations of the COVID-19 epidemic and the clinical and epidemiological characteristics of adult patients with a new coronavirus…”
Get full text

Chronic hepatitis C in Russia: current challenges and prospects by Chulanov, V P, Pimenov, N N, Mamonova, N A, Sagalova, O I, Shestakova, I V, Pokrovsky, V I

“…This paper evaluates the impact of different medical care strategies for chronic hepatitis C patients in relation to its prevalence, frequency of adverse…”
Get full text